Statistics
Publications
46
Citations
2.4K
H-Index
27
Active since
1999
Sherie A. Dowsett is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.
Publications per year
1999–2022
46
46
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Eric Siemers, Karen Sundell, Christopher Carlson et al. · Alzheimer s & Dementia · 2015 · 365 citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
Peter J. Goadsby, David W. Dodick, Massimo Leone et al. · New England Journal of Medicine · 2019 · 255 citations · Full text
1–5 of 46